---
schema_version: "secwatch.filing_event.v1"
accession: "0001668397-26-000034"
form_type: "8-K"
ticker: "MEDP"
cik: "0001668397"
company_name: "Medpace Holdings, Inc."
filed_at: "2026-10-21T20:15:20+00:00"
generated_at: "2026-10-21T20:18:52.630907+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "low"
source: SEC EDGAR
---

# Medpace replaces $527M remaining buyback with new $1.0B authorization through 2028

## Summary
- Board terminated prior repurchase authorization effective Oct 20, 2026, with $527.0M remaining unused, and approved a new authorization of up to $1.0B of common stock through Dec 31, 2028.
- New buybacks will be funded from cash on hand via open market purchases, privately negotiated deals or Rule 10b5-1 plans; no minimum repurchase amount is required.
- Q3 results for the three and nine months ended September 30, 2026 were announced Oct 21, 2026, but Exhibit 99.1 text did not appear in the filing copy, so revenue/EPS figures are unavailable.
- CFO Kevin M. Brady signed the report; the 8-K body contains no other operating or financial detail.

## SEC filing metadata
- accession: 0001668397-26-000034
- form_type: 8-K
- ticker: MEDP
- cik: 0001668397
- company_name: Medpace Holdings, Inc.
- filed_at: 2026-10-21T20:15:20+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: low
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1668397/000166839726000034/0001668397-26-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1668397/000166839726000034/medp-20261020.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001668397-26-000034
- JSON: https://secwatch.observer/filing/0001668397-26-000034.json
- Plain text: https://secwatch.observer/filing/0001668397-26-000034.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.